Racial variation in medical outcomes among living kidney donors.

Risk of end-stage renal disease following live kidney donation. JAMA (2014) 9.63

Gestational hypertension and preeclampsia in living kidney donors. N Engl J Med (2014) 7.25

Kidney-Failure Risk Projection for the Living Kidney-Donor Candidate. N Engl J Med (2015) 5.03

Apolipoprotein L1 gene variants in deceased organ donors are associated with renal allograft failure. Am J Transplant (2015) 2.62

The decline in living kidney donation in the United States: random variation or cause for concern? Transplantation (2013) 1.86

Association of metabolic syndrome with kidney function and histology in living kidney donors. Am J Transplant (2013) 1.63

Impact of socioeconomic status measures on hospital profiling in New York City. Circ Cardiovasc Qual Outcomes (2014) 1.63

A prospective controlled study of kidney donors: baseline and 6-month follow-up. Am J Kidney Dis (2013) 1.55

A prospective controlled study of living kidney donors: three-year follow-up. Am J Kidney Dis (2015) 1.48

Race, Relationship and Renal Diagnoses After Living Kidney Donation. Transplantation (2015) 1.45

Living kidney donors ages 70 and older: recipient and donor outcomes. Clin J Am Soc Nephrol (2011) 1.45

Health-related quality of life in kidney donors from the last five decades: results from the RELIVE study. Am J Transplant (2013) 1.34

Consistency of racial variation in medical outcomes among publicly and privately insured living kidney donors. Transplantation (2014) 1.22

African American living-kidney donors should be screened for APOL1 risk alleles. Transplantation (2011) 1.15

Risks and outcomes of living donation. Adv Chronic Kidney Dis (2012) 1.12

Long-term medical risks to the living kidney donor. Nat Rev Nephrol (2015) 1.00

Hospitalizations following living donor nephrectomy in the United States. Clin J Am Soc Nephrol (2014) 1.00

Big data in organ transplantation: registries and administrative claims. Am J Transplant (2014) 0.99

Living Donor Kidney Transplantation: Overcoming Disparities in Live Kidney Donation in the US--Recommendations from a Consensus Conference. Clin J Am Soc Nephrol (2015) 0.99

Kidney transplant outcomes for prior living organ donors. J Am Soc Nephrol (2014) 0.96

The unjustified classification of kidney donors as patients with CKD: critique and recommendations. Clin J Am Soc Nephrol (2013) 0.95

Making house calls increases living donor inquiries and evaluations for blacks on the kidney transplant waiting list. Transplantation (2014) 0.92

Estimating the long term impact of kidney donation on life expectancy and end stage renal disease. Transplant Res (2013) 0.89

Comorbidity burden and perioperative complications for living kidney donors in the United States. Clin J Am Soc Nephrol (2013) 0.89

Should kidney donors be genotyped for APOL1 risk alleles? Kidney Int (2015) 0.88

Experiences obtaining insurance after live kidney donation. Am J Transplant (2014) 0.86

Low nephron number and its clinical consequences. Rambam Maimonides Med J (2011) 0.85

Geographic information systems and chronic kidney disease: racial disparities, rural residence and forecasting. J Nephrol (2013) 0.85

Innovative strategies in living donor kidney transplantation. Nat Rev Nephrol (2012) 0.84

Living Donor Kidney Transplantation: Facilitating Education about Live Kidney Donation--Recommendations from a Consensus Conference. Clin J Am Soc Nephrol (2015) 0.84

Cancer diagnoses after living kidney donation: linking U.S. Registry data and administrative claims. Transplantation (2012) 0.84

Measuring and explaining racial and ethnic differences in willingness to donate live kidneys in the United States. Clin Transplant (2013) 0.83

Genetic Background is a Key Determinant of Glomerular Extracellular Matrix Composition and Organization. J Am Soc Nephrol (2015) 0.83

Assessment of variation in live donor kidney transplantation across transplant centers in the United States. Transplantation (2011) 0.82

Better understanding live donor risk through big data. Clin J Am Soc Nephrol (2013) 0.81

Gout after living kidney donation: correlations with demographic traits and renal complications. Am J Nephrol (2015) 0.80

An interactive, bilingual, culturally targeted website about living kidney donation and transplantation for hispanics: development and formative evaluation. JMIR Res Protoc (2015) 0.80

End-stage renal disease risk in live kidney donors: what have we learned from two recent studies? Curr Opin Nephrol Hypertens (2014) 0.79

Lack of health insurance in living kidney donors. Clin Transplant (2011) 0.79

Understanding and Communicating Medical Risks for Living Kidney Donors: A Matter of Perspective. J Am Soc Nephrol (2016) 0.78

Obesity increases the risk of end-stage renal disease among living kidney donors. Kidney Int (2016) 0.78

The impact of APOL1, CAV1, and ABCB1 gene variants on outcomes in kidney transplantation: donor and recipient effects. Pediatr Nephrol (2013) 0.78

Development and validation of a questionnaire to assess fear of kidney failure following living donation. Transpl Int (2014) 0.78

The living kidney donor evaluation: focus on renal issues. Clin J Am Soc Nephrol (2012) 0.78

Readiness of wait-listed black patients to pursue live donor kidney transplant. Prog Transplant (2014) 0.78

Gender differences in use of prescription narcotic medications among living kidney donors. Clin Transplant (2015) 0.78

The impact of socioeconomic status and geographic remoteness on access to pre-emptive kidney transplantation and transplant outcomes among children. Pediatr Nephrol (2015) 0.77

Reassessing medical risk in living kidney donors. J Am Soc Nephrol (2014) 0.77

Completion of guideline-recommended initial evaluation of atrial fibrillation. Clin Cardiol (2012) 0.77

Health care follow-up by live kidney donors more than three yr post-nephrectomy. Clin Transplant (2012) 0.77

APOL1 and nephropathy progression in populations of African ancestry. Semin Nephrol (2013) 0.77

Changes in biomarkers associated with living kidney donation. Am J Nephrol (2013) 0.77

Donor race and outcomes in kidney transplant recipients. Clin Transplant (2012) 0.76

Educating Prospective Kidney Transplant Recipients and Living Donors about Living Donation: Practical and Theoretical Recommendations for Increasing Living Donation Rates. Curr Transplant Rep (2016) 0.75

Health Insurance Trends in United States Living Kidney Donors (2004 to 2015). Am J Transplant (2016) 0.75

Barriers to living donor kidney transplantation in the United Kingdom: a national observational study. Nephrol Dial Transplant (2017) 0.75

Long-term effects of kidney donation on renal function and blood pressure in African Americans. Clin J Am Soc Nephrol (2011) 0.75

Impact of Socioeconomic Status on Patients Supported With a Left Ventricular Assist Device: An Analysis of the UNOS Database (United Network for Organ Sharing). Circ Heart Fail (2016) 0.75

Hispanic/Latino Disparities in Living Donor Kidney Transplantation: Role of a Culturally Competent Transplant Program. Transplant Direct (2015) 0.75

Laparoscopic vs open donor nephrectomy: Lessons learnt from single academic center experience. World J Nephrol (2017) 0.75

Outcome of living kidney donors left with multiple renal arteries. Clin Transplant (2011) 0.75

Increasing the supply of kidneys for transplantation by making living donors the preferred source of donor kidneys. Medicine (Baltimore) (2014) 0.75

Approach to the pretransplant evaluation of the living kidney donor. J Transplant (2011) 0.75

Long-term outcomes of living kidney donors are affected by race. Nat Rev Nephrol (2010) 0.75

Summary of Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors. Transplantation (2017) 0.75

The National Landscape of Living Kidney Donor Follow-Up in the United States. Am J Transplant (2017) 0.75

KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors. Transplantation (2017) 0.75

Long-term consequences of kidney donation. N Engl J Med (2009) 10.17

Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988-1994 and 1999-2004. Hypertension (2008) 7.99

Perioperative mortality and long-term survival following live kidney donation. JAMA (2010) 7.34

High survival rates of kidney transplants from spousal and living unrelated donors. N Engl J Med (1995) 5.41

Identifying persons with diabetes using Medicare claims data. Am J Med Qual (2000) 5.02

Non-insulin-dependent diabetes mellitus in minorities in the United States. Ann Intern Med (1996) 4.58

Diabetes mellitus after kidney transplantation in the United States. Am J Transplant (2003) 4.39

Meta-analysis: risk for hypertension in living kidney donors. Ann Intern Med (2006) 4.32

A Report of the Amsterdam Forum On the Care of the Live Kidney Donor: Data and Medical Guidelines. Transplantation (2005) 3.94

Global trends in the rates of living kidney donation. Kidney Int (2009) 3.81

Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes. N Engl J Med (1989) 3.67

The excess incidence of diabetic end-stage renal disease among blacks. A population-based study of potential explanatory factors. JAMA (1992) 3.01

Hypertension prevalence and the status of awareness, treatment, and control in the Hispanic Health and Nutrition Examination Survey (HHANES), 1982-84. Am J Public Health (1990) 2.46

Blood pressure and renal function after kidney donation from hypertensive living donors. Transplantation (2004) 2.22

Sensitivity of billing claims for cardiovascular disease events among kidney transplant recipients. Clin J Am Soc Nephrol (2009) 2.17

Renal transplantation in black Americans. N Engl J Med (2000) 2.17

Risk factors for cardiovascular mortality in Mexican Americans and non-Hispanic whites. San Antonio Heart Study. Am J Epidemiol (1990) 2.03

Practices and barriers in long-term living kidney donor follow-up: a survey of U.S. transplant centers. Transplantation (2009) 1.98

Low rates of testing and diagnostic codes usage in a commercial clinical laboratory: evidence for lack of physician awareness of chronic kidney disease. J Am Soc Nephrol (2005) 1.98

Living kidney donors requiring transplantation: focus on African Americans. Transplantation (2007) 1.92

Disparities in the utilization of live donor renal transplantation. Am J Transplant (2009) 1.87

Cardiovascular disease and hypertension risk in living kidney donors: an analysis of health administrative data in Ontario, Canada. Transplantation (2008) 1.83

Decreased prevalence of hypertension in Mexican-Americans. Hypertension (1990) 1.66

The evolution and direction of OPTN oversight of live organ donation and transplantation in the United States. Am J Transplant (2008) 1.61

Medical risks in living kidney donors: absence of proof is not proof of absence. Clin J Am Soc Nephrol (2006) 1.31

Cardiovascular health in Puerto Ricans compared to other population groups in the United States. Ethn Dis (1991) 1.19

A study of renal outcomes in African American living kidney donors. Transplantation (2009) 1.09

Impact of race and gender on live kidney donation. Clin Transplant (2008) 1.07

Insurance status of U.S. organ donors and transplant recipients: the uninsured give, but rarely receive. Int J Health Serv (2008) 1.03

The system of health insurance for living donors is a disincentive for live donation. Am J Transplant (2010) 1.02

Long-term medical outcomes among Aboriginal living kidney donors. Transplantation (2010) 1.02

International trial of the Edmonton protocol for islet transplantation. N Engl J Med (2006) 13.43

Identification of a novel polyomavirus from patients with acute respiratory tract infections. PLoS Pathog (2007) 8.01

US Renal Data System 2014 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis (2015) 3.94

Survival advantages of obesity in dialysis patients. Am J Clin Nutr (2005) 3.75

Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations. Transplantation (2005) 3.57

Expanding the evidence base in transplantation: the complementary roles of randomized controlled trials and outcomes research. Transplantation (2008) 3.43

Early mobilization of patients hospitalized with community-acquired pneumonia. Chest (2003) 2.85

Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction. Am J Transplant (2005) 2.76

Rate of kidney function decline associates with mortality. J Am Soc Nephrol (2010) 2.76

Liver transplantation cost in the model for end-stage liver disease era: looking beyond the transplant admission. Liver Transpl (2009) 2.38

Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial. Transplantation (2009) 2.33

Awareness of kidney disease and relationship to end-stage renal disease and mortality. Am J Med (2012) 2.24

Incidence and cost of new onset diabetes mellitus among U.S. wait-listed and transplanted renal allograft recipients. Am J Transplant (2003) 2.22

Donor origin of BK virus in renal transplantation and role of HLA C7 in susceptibility to sustained BK viremia. Am J Transplant (2005) 2.19

Sensitivity of billing claims for cardiovascular disease events among kidney transplant recipients. Clin J Am Soc Nephrol (2009) 2.17

Bone morphogenetic proteins in vascular calcification. Circ Res (2005) 2.12

Implementing practical interventions to support chronic illness self-management. Jt Comm J Qual Saf (2003) 2.08

Cost-utility analysis of sodium polystyrene sulfonate vs. potential alternatives for chronic hyperkalemia. Clin Nephrol (2014) 1.98

Incidence and predictors of myocardial infarction after kidney transplantation. J Am Soc Nephrol (2004) 1.93

Asymptomatic autoantibodies associate with future anti-glomerular basement membrane disease. J Am Soc Nephrol (2011) 1.90

Chronic dialysis patients have high risk for pulmonary embolism. Am J Kidney Dis (2002) 1.82

The interaction among donor characteristics, severity of liver disease, and the cost of liver transplantation. Liver Transpl (2011) 1.79

Nomogram for predicting the likelihood of delayed graft function in adult cadaveric renal transplant recipients. J Am Soc Nephrol (2003) 1.77

Kidney transplantation as primary therapy for end-stage renal disease: a National Kidney Foundation/Kidney Disease Outcomes Quality Initiative (NKF/KDOQITM) conference. Clin J Am Soc Nephrol (2008) 1.76

Bariatric surgery among kidney transplant candidates and recipients: analysis of the United States renal data system and literature review. Transplantation (2009) 1.75

Discovery of STL polyomavirus, a polyomavirus of ancestral recombinant origin that encodes a unique T antigen by alternative splicing. Virology (2012) 1.75

Living donation decision making: recipients' concerns and educational needs. Prog Transplant (2006) 1.73

Canadian society of transplantation consensus workshop on cytomegalovirus management in solid organ transplantation final report. Am J Transplant (2005) 1.73

Association of oral sodium phosphate purgative use with acute kidney injury. J Am Soc Nephrol (2007) 1.72

Report of the first international liver transplantation society expert panel consensus conference on renal insufficiency in liver transplantation. Liver Transpl (2009) 1.69

Health insurance considerations for adolescent transplant recipients as they transition to adulthood. Pediatr Transplant (2007) 1.68

Nephrogenic systemic fibrosis: a mysterious disease in patients with renal failure--role of gadolinium-based contrast media in causation and the beneficial effect of intravenous sodium thiosulfate. Clin J Am Soc Nephrol (2007) 1.68

Transplantation of A2 kidneys into B and O recipients leads to reduction in waiting time: USRDS experience. Transplantation (2010) 1.60

Impact of prophylactic versus preemptive valganciclovir on long-term renal allograft outcomes. Transplantation (2010) 1.57

Arteriovenous fistulas among incident hemodialysis patients in Department of Defense and Veterans Affairs facilities. J Am Soc Nephrol (2010) 1.56

Assessment of racial disparities in chronic kidney disease stage 3 and 4 care in the department of defense health system. Clin J Am Soc Nephrol (2008) 1.56

Kidney transplant chains amplify benefit of nondirected donors. JAMA Surg (2013) 1.52

Incidence, predictors and associated outcomes of rhabdomyolysis after kidney transplantation. Nephrol Dial Transplant (2009) 1.52

Reproduction and transplantation: report on the AST Consensus Conference on Reproductive Issues and Transplantation. Am J Transplant (2005) 1.52

Portal vein thrombosis complicating islet transplantation in a recipient with the Factor V Leiden mutation. Transplantation (2004) 1.51

Higher levels of leflunomide are associated with hemolysis and are not superior to lower levels for BK virus clearance in renal transplant patients. Clin J Am Soc Nephrol (2008) 1.45

Race, Relationship and Renal Diagnoses After Living Kidney Donation. Transplantation (2015) 1.45

Lifetime cost-effectiveness of calcineurin inhibitor withdrawal after de novo renal transplantation. J Am Soc Nephrol (2008) 1.45

Transplant certification and quality assessment: time to take the front line? Prog Transplant (2013) 1.43

Cost Implications of New National Allocation Policy for Deceased Donor Kidneys in the United States. Transplantation (2016) 1.42

Will dialysis prevent the development of nephrogenic systemic fibrosis after gadolinium-based contrast administration? AJR Am J Roentgenol (2007) 1.42

Response to 'viral hepatitis guidelines for transplant recipients'. Am J Transplant (2005) 1.39

No independent association of serum phosphorus with risk for death or progression to end-stage renal disease in a large screen for chronic kidney disease. Kidney Int (2013) 1.38

US Renal Data System 2015 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis (2016) 1.37

BK virus nephropathy and kidney transplantation. Clin J Am Soc Nephrol (2007) 1.36

Dementia as a predictor of mortality in dialysis patients. Clin J Am Soc Nephrol (2006) 1.36

Damned if you do, damned if you don't: potassium binding resins in hyperkalemia. Clin J Am Soc Nephrol (2010) 1.35

Thrombotic microangiopathy after renal transplantation in the United States. Am J Kidney Dis (2003) 1.34

Intestinal and hepatic CYP3A4 catalyze hydroxylation of 1alpha,25-dihydroxyvitamin D(3): implications for drug-induced osteomalacia. Mol Pharmacol (2005) 1.33

Cost-effectiveness of extending Medicare coverage of immunosuppressive medications to the life of a kidney transplant. Am J Transplant (2004) 1.33

The interplay of socioeconomic status, distance to center, and interdonor service area travel on kidney transplant access and outcomes. Clin J Am Soc Nephrol (2010) 1.32

Impact of renal transplantation on survival in end-stage renal disease patients with elevated body mass index. Kidney Int (2003) 1.32

An OPTN analysis of national registry data on treatment of BK virus allograft nephropathy in the United States. Transplantation (2009) 1.31

Myeloma, Hodgkin disease, and lymphoid leukemia after renal transplantation: characteristics, risk factors and prognosis. Transplantation (2006) 1.29

Alemtuzumab induction and prednisone-free maintenance immunotherapy in kidney transplantation: comparison with basiliximab induction--long-term results. Am J Transplant (2005) 1.29

Association between lack of health insurance and risk of death and ESRD: results from the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis (2013) 1.29

Predictors of ARF after cardiac surgical procedures. Am J Kidney Dis (2003) 1.28

Resource utilization in patients hospitalized with heart failure: insights from a contemporary national hospital database. Am Heart J (2008) 1.27

Incident acute coronary syndromes in chronic dialysis patients in the United States. Kidney Int (2002) 1.27

Progressive multifocal leukoencephalopathy and use of mycophenolate mofetil after kidney transplantation. Transplantation (2008) 1.27

CKD awareness in the United States: the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis (2008) 1.26

BK virus antibody titers and intensity of infections after renal transplantation. J Clin Virol (2008) 1.25

Renal osteodystrophy, phosphate homeostasis, and vascular calcification. Semin Dial (2007) 1.24

Effect of CYP3A5 polymorphism on tacrolimus metabolic clearance in vitro. Drug Metab Dispos (2006) 1.22

Consistency of racial variation in medical outcomes among publicly and privately insured living kidney donors. Transplantation (2014) 1.22

The expanded criteria donor dilemma in cadaveric renal transplantation. Transplantation (2003) 1.22

Delivery patterns of recommended chronic kidney disease care in clinical practice: administrative claims-based analysis and systematic literature review. Clin Exp Nephrol (2008) 1.21

Association of incident gout and mortality in dialysis patients. J Am Soc Nephrol (2008) 1.20

Incidence and risk factors for diarrhea following kidney transplantation and association with graft loss and mortality. Am J Kidney Dis (2008) 1.20

HIV-associated nephropathy and end-stage renal disease in children in the United States. Pediatr Nephrol (2004) 1.19

Effect of donor factors on early graft survival in adult cadaveric renal transplantation. Am J Transplant (2002) 1.19

An inducible cytochrome P450 3A4-dependent vitamin D catabolic pathway. Mol Pharmacol (2011) 1.18